Page last updated: 2024-09-04

ertiprotafib and nsc 663284

ertiprotafib has been researched along with nsc 663284 in 1 studies

Compound Research Comparison

Studies
(ertiprotafib)
Trials
(ertiprotafib)
Recent Studies (post-2010)
(ertiprotafib)
Studies
(nsc 663284)
Trials
(nsc 663284)
Recent Studies (post-2010) (nsc 663284)
161828020

Protein Interaction Comparison

ProteinTaxonomyertiprotafib (IC50)nsc 663284 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus2.63
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.63
M-phase inducer phosphatase 1Homo sapiens (human)1.015
M-phase inducer phosphatase 2Homo sapiens (human)0.77
M-phase inducer phosphatase 3Homo sapiens (human)0.505
Dual specificity protein phosphatase 3Homo sapiens (human)4
N-lysine methyltransferase KMT5AHomo sapiens (human)0.21

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rauh, D; Vintonyak, VV; Waldmann, H1

Other Studies

1 other study(ies) available for ertiprotafib and nsc 663284

ArticleYear
Using small molecules to target protein phosphatases.
    Bioorganic & medicinal chemistry, 2011, Apr-01, Volume: 19, Issue:7

    Topics: Animals; Drug Delivery Systems; Enzyme Inhibitors; Humans; Mice; Models, Molecular; Molecular Targeted Therapy; Phosphorylation; Protein Binding; Protein Tyrosine Phosphatases; Rats

2011